These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29703584)

  • 1. [Medulloblastoma. Pathology].
    Siegfried A; Delisle MB
    Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
    Pietsch T; Haberler C
    Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
    Cambruzzi E
    Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
    Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
    J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
    Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
    Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Medulloblastoma Revisited.
    Cassia GSE; Alves CAPF; Taranath A; López NS; Oztekin O; Gonçalves FG; Patay Z
    Top Magn Reson Imaging; 2018 Dec; 27(6):479-502. PubMed ID: 30516696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.
    McManamy CS; Pears J; Weston CL; Hanzely Z; Ironside JW; Taylor RE; Grundy RG; Clifford SC; Ellison DW;
    Brain Pathol; 2007 Apr; 17(2):151-64. PubMed ID: 17388946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].
    Pietsch T
    Pathologe; 2019 Mar; 40(2):140-147. PubMed ID: 30790012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
    Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
    Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
    Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
    PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience.
    Badiger S; Gudipati A; Uppin M; Konatam ML; Yeramneni VK; Bhattacharjee S; Saradhi MV; Patnaik S; Irukulla M
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S592-S602. PubMed ID: 38384024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medulloblastoma].
    Yamaguchi S; Fujimura M
    No Shinkei Geka; 2023 Sep; 51(5):858-866. PubMed ID: 37743337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
    Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U
    J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
    Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of medulloblastoma in children under age of three years.
    Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
    Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup?
    Liu APY; Priesterbach-Ackley LP; Orr BA; Li BK; Gudenas B; Reddingius RE; Suñol M; Lavarino CE; Olaciregui NG; Santa-María López V; Fisher MJ; Hazrati LN; Bouffet E; Huang A; Robinson GW; Wesseling P; Northcott PA; Gajjar A
    Acta Neuropathol; 2020 Oct; 140(4):595-597. PubMed ID: 32772175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.